CINECA IRIS Institutional Research Information System

MULATERO, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.609
EU - Europa 9.842
AS - Asia 8.951
SA - Sud America 1.599
OC - Oceania 394
AF - Africa 248
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.476
CN - Cina 4.511
IT - Italia 2.061
DE - Germania 1.360
JP - Giappone 1.219
FR - Francia 839
IE - Irlanda 804
MX - Messico 690
ES - Italia 627
BR - Brasile 597
SG - Singapore 568
GB - Regno Unito 537
SE - Svezia 516
UA - Ucraina 478
FI - Finlandia 418
KR - Corea 394
CA - Canada 381
PL - Polonia 368
AU - Australia 361
VN - Vietnam 345
CO - Colombia 328
TR - Turchia 310
IN - India 298
TW - Taiwan 298
AT - Austria 279
HK - Hong Kong 256
AR - Argentina 251
CH - Svizzera 184
RU - Federazione Russa 179
CL - Cile 178
GR - Grecia 178
ID - Indonesia 160
TH - Thailandia 159
NL - Olanda 155
BE - Belgio 147
PT - Portogallo 144
RO - Romania 115
PE - Perù 101
EC - Ecuador 82
CZ - Repubblica Ceca 66
MY - Malesia 66
DZ - Algeria 58
IL - Israele 52
BG - Bulgaria 47
SA - Arabia Saudita 45
DK - Danimarca 43
HU - Ungheria 43
ZA - Sudafrica 43
AE - Emirati Arabi Uniti 36
HR - Croazia 33
IR - Iran 33
NZ - Nuova Zelanda 33
PH - Filippine 32
SK - Slovacchia (Repubblica Slovacca) 31
NO - Norvegia 27
MA - Marocco 26
VE - Venezuela 26
EG - Egitto 25
LT - Lituania 25
RS - Serbia 25
BA - Bosnia-Erzegovina 24
IQ - Iraq 20
BD - Bangladesh 19
TN - Tunisia 19
JO - Giordania 18
BY - Bielorussia 17
SI - Slovenia 17
DO - Repubblica Dominicana 16
OM - Oman 13
QA - Qatar 13
MT - Malta 12
PK - Pakistan 11
PY - Paraguay 11
SN - Senegal 11
UY - Uruguay 11
BO - Bolivia 10
LB - Libano 10
NG - Nigeria 10
CR - Costa Rica 9
KE - Kenya 9
PA - Panama 9
MU - Mauritius 8
UG - Uganda 8
UZ - Uzbekistan 8
IS - Islanda 7
KW - Kuwait 7
LK - Sri Lanka 7
LU - Lussemburgo 7
RE - Reunion 7
AL - Albania 6
HN - Honduras 6
MD - Moldavia 6
SV - El Salvador 6
EE - Estonia 5
EU - Europa 5
GE - Georgia 5
KZ - Kazakistan 5
NP - Nepal 5
PR - Porto Rico 5
CD - Congo 4
Totale 31.573
Salva come PNG Salva come JPEG
Città #
Beijing 1.197
Chandler 967
Dublin 770
Houston 716
Fairfield 555
Redwood City 450
Torino 434
Singapore 400
Ann Arbor 393
Ashburn 357
Wilmington 332
Jacksonville 294
Villeurbanne 293
Tokyo 280
Shanghai 273
Woodbridge 259
Medford 249
Seattle 249
Vienna 245
Princeton 224
Warsaw 216
Dong Ket 209
Munich 202
Cambridge 195
Guangzhou 179
Chongqing 171
Milan 166
Turin 166
Nyköping 155
Taipei 155
New York 143
Buenos Aires 137
Bogotá 134
São Paulo 134
Chengdu 132
Madrid 132
Santiago 127
Pisa 121
Istanbul 106
Mexico City 106
Jakarta 101
Barcelona 99
Hangzhou 99
Nanjing 99
Dearborn 95
Boston 92
Paris 90
Fremont 88
Rome 84
Changsha 82
Lima 82
Melbourne 82
Wuhan 82
Central 78
Bangkok 75
Düsseldorf 74
London 73
Athens 72
Shenzhen 66
Berlin 64
Padova 63
Sydney 62
Zhengzhou 61
Chicago 60
Verona 59
Ankara 58
Medellín 56
Boardman 53
Shenyang 51
Norwalk 50
Los Angeles 49
Ottawa 49
Seoul 49
Toronto 49
Tianjin 48
Bologna 47
San Diego 47
Falls Church 46
Osaka 45
Montreal 44
Rochester 44
Brisbane 43
Ho Chi Minh City 42
Kunming 42
Santa Clara 42
Helsinki 41
Valencia 41
Bucharest 40
Fuzhou 40
Guadalajara 40
Moscow 40
Mumbai 40
Rio de Janeiro 40
Quito 38
Brussels 37
Monterrey 37
Zurich 37
Hebei 36
New Delhi 35
Perth 35
Totale 15.536
Salva come PNG Salva come JPEG
Nome #
Diagnosis and treatment of primary aldosteronism 7.009
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension 2.067
Renal damage in primary aldosteronism: a systematic review and meta-analysis 795
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. 717
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in pr imar y aldosteronism 689
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice 625
Guidelines for primary aldosteronism: uptake by primary care physicians in Europe 611
Primary aldosteronism in the primary care setting 579
The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism 539
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism 508
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series 373
Hyperaldosteronism: How to Discriminate Among Different Disease Forms? 368
The spectrum of low-renin hypertension 367
Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism 335
The expanding genetic horizon of primary aldosteronism 331
Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful 330
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 318
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. 313
Primary aldosteronism in the elderly 300
Subtype Diagnosis of Primary Aldosteronism: Approach to Different Clinical Scenarios 297
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study 297
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma 287
Coexisting prolactinoma and primary aldosteronism: Is there a pathophysiological link? 276
Aldosterone effects on glomerular structure and function 271
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. 269
Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link? 234
Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism 219
Is there a role for genomics in the management of hypertension? 217
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 208
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? 199
Assessing resting heart rate in adolescents: determinants and correlates. 198
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism 194
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas 188
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 177
Combinations of Renin-Angiotensin-Aldosterone System Antagonists: True Advantages? 169
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism 164
Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism 162
Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism 152
Antihypertensive Bridge Therapy by Continuous Drug Infusion with an Elastomeric Pump in Device-Resistant Hypertension 148
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes 148
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III 141
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism 141
Aldosterone does not modify gene expression in human endothelial cells 135
Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism 134
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 133
Case of Primary Aldosteronism with Discordant Hormonal and Computed Tomographic Findings 128
Classification of microadenomas in patients with primary aldosteronism by steroid profiling 128
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients with Primary Aldosteronism 123
Familial hyperaldosteronism type III 122
TRATTAMENTO PRE- E POST-OPERATORIO 121
Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit 121
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions 120
Quality of life in primary aldosteronism: A prospective observational study 117
Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients 110
10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy 110
Adiponectin and insulin sensitivity in primary aldosteronism. 108
Is Primary Aldosteronism Still Largely Unrecognized? 107
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge kir3.4 residue. 104
Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism 103
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism 103
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial 100
Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism 99
Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism 99
Liddle syndrome: Review of the literature and description of a new case 97
alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes. 96
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis 94
Antihypertensive drugs and the sympathetic nervous system 92
Aldosterone as an independent factor in cerebrovascular damage 89
11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. 88
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 88
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 88
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms 86
A particular phenotype in a girl with aldosterone synthase deficiency 85
Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. 85
Aortic size index enlargement is associated with central hemodynamics in essential hypertension 80
A case of adrenal vein sampling in primary aldosteronism with homolateral suppression 80
Recent advances in diagnosis and treatment of primary aldosteronism. 77
Absence of D147E mutation of CYP11B2 gene in hypertensive patients with increased corticosterone and aldosterone production. 75
Genetics of primary aldosteronism 75
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism 75
Diagnosis and treatment of low-renin hypertension 73
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism 72
A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol. 69
Mouse models of primary aldosteronism: From physiology to pathophysiology 69
Blood pressure in patients with primary aldosteronism is influenced by bradykinin B(2) receptor and alpha-adducin gene polymorphisms. 68
Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. 68
Alpha1-adrenergic receptor subtypes in peripheral blood lymphocytes of essential hypertensives. 68
Atypical secondary hypertension due to mid-aortic syndrome 68
Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11beta-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11beta-hydroxylase deficiency and congenital adrenal hyperplasia. 67
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT) 67
The SPARTACUS Trial: Controversies and Unresolved Issues 66
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement 66
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism 65
Diagnosis and treatment of unilateral forms of primary aldosteronism 65
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis. 64
Visinin-Like 1 Is Upregulated in Aldosterone-Producing Adenomas With KCNJ5 Mutations and Protects From Calcium-Induced Apoptosis. 64
Bradykinin B2 receptor gene (-58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients 64
Conceptual basis and methodology of the SOPHIA study 64
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). 63
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples 63
Totale 27.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.771 0 0 0 265 265 622 270 254 314 212 274 295
2020/20213.444 253 272 284 191 335 272 288 149 306 336 288 470
2021/20223.698 245 297 236 281 302 245 233 246 279 236 466 632
2022/20236.243 438 292 219 550 480 989 535 489 638 383 597 633
2023/20247.679 714 770 631 631 661 701 607 606 229 632 814 683
2024/20252.527 596 688 732 511 0 0 0 0 0 0 0 0
Totale 32.366